AATI develops, manufactures and markets high-throughput, fully-automated nucleic acid and genetic analysis systems. The company's products have both commercial and research applications and are designed to improve processes within the molecular diagnostics, pharmaceutical, life science, agricultural and biofuels industries. The company's product portfolio includes instruments for the parallel analysis of biomolecules, DNA, RNA, genomic DNA, double-stranded DNA, pharmaceutical compounds and proteins using capillary electrophoresis (CE) with fluorescence detection or UV absorbance.
The company's flagship product, the Fragment AnalyzerTM, is recognized as the best-in-class, multi-channel, automated fluorescence-based CE detection system for the simultaneous analysis of the quantity and quality of nucleic acids, including: dsDNA fragments, gDNA, NGS fragments and RNA (total and messenger) and microsatellites (SSR).
Our technology platform also powers Oligo PROTM for oligonucleotide analyses and pKa PROTM for measuring acid dissociation constants.
The company has facilities in Ankeny, Iowa, USA; Paris, France and Heidelberg, Germany. We support customers through a global network of distributors and support centers.